全文获取类型
收费全文 | 217篇 |
免费 | 9篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 2篇 |
儿科学 | 5篇 |
妇产科学 | 10篇 |
基础医学 | 33篇 |
口腔科学 | 2篇 |
临床医学 | 11篇 |
内科学 | 48篇 |
皮肤病学 | 1篇 |
神经病学 | 16篇 |
特种医学 | 3篇 |
外科学 | 19篇 |
综合类 | 11篇 |
预防医学 | 17篇 |
眼科学 | 9篇 |
药学 | 28篇 |
中国医学 | 2篇 |
肿瘤学 | 10篇 |
出版年
2023年 | 2篇 |
2022年 | 7篇 |
2021年 | 9篇 |
2020年 | 7篇 |
2019年 | 1篇 |
2018年 | 4篇 |
2017年 | 2篇 |
2016年 | 2篇 |
2015年 | 6篇 |
2014年 | 3篇 |
2013年 | 6篇 |
2012年 | 15篇 |
2011年 | 15篇 |
2010年 | 5篇 |
2009年 | 14篇 |
2008年 | 12篇 |
2007年 | 15篇 |
2006年 | 11篇 |
2005年 | 16篇 |
2004年 | 9篇 |
2003年 | 6篇 |
2002年 | 11篇 |
2001年 | 7篇 |
2000年 | 3篇 |
1999年 | 6篇 |
1997年 | 1篇 |
1996年 | 1篇 |
1995年 | 4篇 |
1994年 | 1篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 1篇 |
1989年 | 1篇 |
1988年 | 1篇 |
1987年 | 2篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1983年 | 2篇 |
1982年 | 1篇 |
1981年 | 3篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1968年 | 1篇 |
1967年 | 1篇 |
1966年 | 1篇 |
1965年 | 1篇 |
排序方式: 共有227条查询结果,搜索用时 15 毫秒
221.
We compared the prevalence and management of metabolic syndrome (MetS) and its components in men and women with peripheral artery disease (PAD). A total of 70 men and 70 women with PAD were evaluated for presence of MetS. There was no significant gender difference in presence of MetS (P = .399) and the number of MetS components (P = .411). Among PAD patients with each MetS component, there was no significant gender difference in the use (P = .617) and number (P = .716) of blood pressure medications, the use (P = .593) and number (P = .591) of lipid-lowering medications, and the number (P = .155) of diabetic medications. Significantly more women were treated with diabetic medications compared with men (85 vs 57%, P = .026). The prevalence and management of MetS and its components was similar between men and women with PAD, except that more women were treated for diabetes. Patients with PAD having MetS did not receive optimal medical management. 相似文献
222.
Gowthaman U Singh V Zeng W Jain S Siddiqui KF Chodisetti SB Gurram RK Parihar P Gupta P Gupta UD Jackson DC Agrewala JN 《The Journal of infectious diseases》2011,204(9):1328-1338
One of the main reasons considered for BCG failure in tuberculosis-endemic areas is impediment by environmental mycobacteria in its processing and generation of memory T-cell response. To overcome this problem, we developed a unique lipopeptide (L91) by linking the promiscuous peptide (sequence 91-110) of 16 kDa antigen of Mycobacterium tuberculosis to Pam2Cys. L91 does not require extensive antigen processing and generates enduring Th1 memory response. This is evidenced by the fact that L91 significantly improved the activation, proliferation, and generation of protective T cells. Furthermore, L91 surmounts the barrier of major histocompatibility complex polymorphism and induces better protection than BCG. This peptide has self-adjuvanting properties and activates dendritic cells. Importantly, L91 activates T cells isolated from purified protein derivative-positive healthy volunteers that responded weakly to free peptide (F91). In essence, L91 can be a potent future vaccine candidate against tuberculosis. 相似文献
223.
224.
Mahmoodian H Hamiruce Marhaban M Abdulrahim R Rosli R Saripan I 《Australasian physical & engineering sciences in medicine / supported by the Australasian College of Physical Scientists in Medicine and the Australasian Association of Physical Sciences in Medicine》2011,34(1):41-54
The classification of the cancer tumors based on gene expression profiles has been extensively studied in numbers of studies.
A wide variety of cancer datasets have been implemented by the various methods of gene selection and classification to identify
the behavior of the genes in tumors and find the relationships between them and outcome of diseases. Interpretability of the
model, which is developed by fuzzy rules and linguistic variables in this study, has been rarely considered. In addition,
creating a fuzzy classifier with high performance in classification that uses a subset of significant genes which have been
selected by different types of gene selection methods is another goal of this study. A new algorithm has been developed to
identify the fuzzy rules and significant genes based on fuzzy association rule mining. At first, different subset of genes
which have been selected by different methods, were used to generate primary fuzzy classifiers separately and then proposed
algorithm was implemented to mix the genes which have been associated in the primary classifiers and generate a new classifier.
The results show that fuzzy classifier can classify the tumors with high performance while presenting the relationships between
the genes by linguistic variables. 相似文献
225.
226.
Amrita Datta Chaudhuri Raha M. Dasgheyb Lauren R. DeVine Honghao Bi Robert N. Cole Norman J. Haughey 《Glia》2020,68(1):128-144
Extracellular vesicles have now emerged as key players in cell-to-cell communication. This is particularly important in the central nervous system, where glia–neuron cross-talk helps maintain normal neuronal function. Astrocyte-derived extracellular vesicles (ADEVs) secreted constitutively promote neurite outgrowth and neuronal survival. However, extracellular stimuli can alter the cargo and downstream functions of ADEVs. For example, ADEVs secreted in response to inflammation contain cargo microRNAs and proteins that reduce neurite outgrowth, neuronal firing, and promote neuronal apoptosis. We performed a comprehensive quantitative proteomic analysis to enumerate the proteomic cargo of ADEVs secreted in response to multiple stimuli. Rat primary astrocytes were stimulated with a trophic stimulus (adenosine triphosphate, ATP), an inflammatory stimulus (IL-1β) or an anti-inflammatory stimulus (IL10) and extracellular vesicles secreted within a 2 hr time frame were collected using sequential ultracentrifugation method. ADEVs secreted constitutively without exposure to any stimulus were used a control. A tandem mass tag-based proteomic platform was used to identify and quantify proteins in the ADEVs. Ingenuity pathway analysis was performed to predict the downstream signaling events regulated by ADEVs. We found that in response to ATP or IL10, ADEVs contain a set of proteins that are involved in increasing neurite outgrowth, dendritic branching, regulation of synaptic transmission, and promoting neuronal survival. In contrast, ADEVs secreted in response to IL-1β contain proteins that regulate peripheral immune response and immune cell trafficking to the central nervous system. 相似文献
227.
Anita Y.M. Kwan Hertzel C. Gerstein Jan Basile Denis Xavier Juan M. Maldonado Sohini Raha Manige Konig 《Diabetes care》2022,45(3):547
OBJECTIVETo evaluate participant characteristics and long-term changes in glycated hemoglobin (HbA1c) levels in patients treated with dulaglutide 1.5 mg in a post hoc analysis of the Researching cardiovascular Events with a Weekly INcretin in Diabetes (REWIND) trial.RESEARCH DESIGN AND METHODSChange from baseline in HbA1c was assessed during and up to 72 months of treatment before and after adjustment for duration of diabetes, prior microvascular disease (nephropathy or retinopathy), and BMI. Slope analyses were used to assess the change in HbA1c during 0–12 months and 12–72 months of therapy.RESULTSHbA1c was significantly reduced in patients treated with dulaglutide compared with placebo during 72 months of treatment (least-squares mean difference = −0.61%, P < 0.001), regardless of diabetes duration, prior microvascular disease, and BMI (all interaction P > 0.07). Significant reductions were apparent at all time points and were independent of these baseline characteristics. Slope analyses revealed that the dulaglutide group experienced a higher rate of HbA1c reduction compared with the placebo group from 0 to 12 months before and after adjustment. The dulaglutide group also experienced a higher rate of HbA1c increase from 12 to 72 months compared with the placebo group that became nonsignificant after adjustment for diabetes duration, prior microvascular disease, and BMI combined. Despite the greater rate of HbA1c increase in the dulaglutide group during this period, mean HbA1c values remained below baseline in the dulaglutide group and below mean HbA1c values in the placebo group.CONCLUSIONSDulaglutide 1.5-mg treatment was statistically associated with a long-lasting decrease in HbA1c over 72 months, irrespective of baseline duration of diabetes, microvascular disease, and BMI. 相似文献